Cargando…
TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review
BACKGROUND: Perivascular epitheloid cell tumor (PEComas) are characterized by expression of both muscles, most often smooth muscle actin (in ~80% of cases) and melanocytic markers (mainly HMB-45 and Melan A). TFE 3-associated PEComas are new variant which are poorly defined due to their limited repo...
Autores principales: | Purwar, Roli, Soni, Kishan, Shukla, Mridula, Verma, Ashish, Kumar, Tarun, Pandey, Manoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886828/ https://www.ncbi.nlm.nih.gov/pubmed/35232443 http://dx.doi.org/10.1186/s12957-021-02462-5 |
Ejemplares similares
-
TFE3-Expressing Perivascular Epithelioid Cell Tumor of the Breast
por: Kim, Hyunjin, et al.
Publicado: (2019) -
Tubo-ovarian mass with raised CA-125 in a 21-year-old female
por: Purwar, Roli, et al.
Publicado: (2022) -
Cancer surgery during COVID increased the patient mortality and the transmission risk to healthcare workers: results from a retrospective cohort study (NCT05240378)
por: Soni, Kishan, et al.
Publicado: (2022) -
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
por: Gennatas, Constantine, et al.
Publicado: (2012) -
Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials
por: Purwar, Roli, et al.
Publicado: (2022)